Imax price target raised to $24 from $22 at Wedbush

Wedbush raised the firm’s price target on Imax to $24 from $22 and keeps an Outperform rating on the shares. Wedbush keeps Imax on the firm’s Best Ideas List, given the view that Imax is gaining market share as moviegoers increasingly prefer IMAX screens, significantly expanding its filmed-for-IMAX partnerships, which should drive incremental market share gains in 2025, and diversifying with more alternative content to boost revenue further, the analyst tells investors in a research note. The firm expects Imax will return to peak EBITDA margins in the next three years.